• 2015

Company Description

angioClast is a Cambridge biotech startup comitted to transform cancer research.

angioClast is a Cambridge biotech startup comitted to transform cancer research. Through the application of de novo markers of cancer blood vessels, angioClast strives to develop and revolutionize the treatment and diagnosis of various cancer types.

  • Manufacturer:

    Science and Engineering
  • Formed:

    2015
  • Founders:

    Minaam Abbas
  • Company Website:

  • Company E-mail:

  • Company Address:

    Accelerate Cambridge, Trumpington Street
    Cambridge
    United Kingdom
  • CEO:

    • Minaam Abbas